ArticlePloS one2018

Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.

Olga Ksionda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.